These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3075462)
41. Auto-MHC class II-reactive T cell line obtained from MRL/+mice suffering from "lpr-GVHD". I. Characterization of surface phenotypes, specificities and functions in vitro. Nagata N; Yasumizu R; Ohnishi Y; Nakagawa T; Inaba M; Ikehara S Immunobiology; 1990 Nov; 181(4-5):367-78. PubMed ID: 2099906 [TBL] [Abstract][Full Text] [Related]
42. Increased superoxide anion production and glutathione peroxidase activity in peritoneal macrophages from autoimmune-prone MRL/Mp-Ipr/lpr mice. Rokutan K; Hosokawa T; Nakamura K; Koyama K; Aoike A; Kawai K Int Arch Allergy Appl Immunol; 1988; 87(2):113-9. PubMed ID: 2847985 [TBL] [Abstract][Full Text] [Related]
43. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice. Suh CH; Freed JH; Cohen PL J Immunol; 2003 Feb; 170(4):2229-35. PubMed ID: 12574397 [TBL] [Abstract][Full Text] [Related]
44. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157 [TBL] [Abstract][Full Text] [Related]
45. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044 [TBL] [Abstract][Full Text] [Related]
46. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis. Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126 [TBL] [Abstract][Full Text] [Related]
47. beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. Christianson GJ; Blankenburg RL; Duffy TM; Panka D; Roths JB; Marshak-Rothstein A; Roopenian DC J Immunol; 1996 Jun; 156(12):4932-9. PubMed ID: 8648144 [TBL] [Abstract][Full Text] [Related]
48. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice. Lenda DM; Stanley ER; Kelley VR J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612 [TBL] [Abstract][Full Text] [Related]
49. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus. Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816 [TBL] [Abstract][Full Text] [Related]
50. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice]. Kobayashi K; Hamano T; Kakishita E Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824 [TBL] [Abstract][Full Text] [Related]
51. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice. Lu Q; Shen N; Li XM; Chen SL Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792 [TBL] [Abstract][Full Text] [Related]
52. [Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice]. Wang ZH; Zhang W; Zhang YQ; Pang CY; Wang YF Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):771-776. PubMed ID: 27752154 [TBL] [Abstract][Full Text] [Related]
53. The characteristics of hematopoietic stem cells from autoimmune-prone mice and the role of neural cell adhesion molecules in abnormal proliferation of these cells in MRL/lpr mice. Wang X; Hisha H; Cui W; Song C; Mizokami T; Okazaki S; Li Q; Feng W; Kato J; Jiang S; Fan H; Ikehara S Haematologica; 2007 Mar; 92(3):300-7. PubMed ID: 17339178 [TBL] [Abstract][Full Text] [Related]
54. The liver of MRL/lpr mice contains defective accessory cells and a population of immunosuppressive lymphocytes. Magilavy DB; Rowley DA; Davis M Cell Immunol; 1990 Feb; 125(2):469-79. PubMed ID: 2137036 [TBL] [Abstract][Full Text] [Related]
55. Spontaneous production of interleukin 3 by T lymphocytes from autoimmune MRL/MP-lpr/lpr mice. Palacios R Eur J Immunol; 1984 Jul; 14(7):599-605. PubMed ID: 6430708 [TBL] [Abstract][Full Text] [Related]
56. Delayed onset of autoreactive antibody production and M2-skewed macrophages contribute to improved survival of TACI deficient MRL-Fas/Lpr mouse. Liu L; Allman WR; Coleman AS; Takeda K; Lin TL; Akkoyunlu M Sci Rep; 2018 Jan; 8(1):1308. PubMed ID: 29358664 [TBL] [Abstract][Full Text] [Related]
57. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655 [TBL] [Abstract][Full Text] [Related]
58. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Drappa J; Brot N; Elkon KB Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292 [TBL] [Abstract][Full Text] [Related]